Evidence map›Paper›PMID 9199335›Full record

ArticleMolecular and cellular biology1997

Characterization of a neuregulin-related gene, Don-1, that is highly expressed in restricted regions of the cerebellum and hippocampus.

S J Busfield, D A Michnick, T W Chickering, T L Revett, J Ma, E A Woolf, C A Comrack, B J Dussault, J Woolf, A D Goodearl and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 116 citations in OpenAlex.

  1. Review
  2. Neuregulin 2 Is a Candidate Gene for Autism Spectrum Disorder.International journal of molecular sciences · 2024
    Article
  3. Review
  4. Analysis of CD74 Occurrence in Oncogenic Fusion Proteins.International journal of molecular sciences · 2023
    Review
  5. Neuregulins in Neurodegenerative Diseases.Frontiers in aging neuroscience · 2021
    Article
  6. Proteolytic Processing of Neuregulin 2.Molecular neurobiology · 2020
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

S J BusfieldMillennium Pharmaceuticals Incorporated, Cambridge, Massachusetts 02139, USA. busfield@mpi.com
D A Michnick
T W Chickering
T L Revett
J Ma
E A Woolf
C A Comrack
B J Dussault
J Woolf
A D Goodearl
D P Gearing
Millennium Engineering and Integration (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Members of the epidermal growth factor family of receptors have long been implicated in the pathogenesis of various tumors, and more recently, apparent roles in the developing heart and nervous system have been described. Numerous ligands that activate these receptors have been isolated. We report here on the cloning and initial characterization of a second ligand for the erbB family of receptors. This factor, which we have termed Don-1 (divergent of neuregulin 1), has structural similarity with the neuregulins. We have isolated four splice variants, two each from human and mouse, and have shown that they are capable of inducing tyrosine phosphorylation of erbB3, erbB4, and erbB2. In contrast to those of neuregulin, high levels of expression of Don-1 are restricted to the cerebellum and dentate gyrus in the adult brain and to fetal tissues.

Indexed as

Amino Acid SequenceAnimalsCell DivisionCerebellumChromosome MappingChromosomes, Human, Pair 5Cloning, MolecularGene ExpressionGenetic LinkageGlycoproteinsHippocampusHumansIn Situ HybridizationLigandsMembrane ProteinsMiceGlycoproteinsLigandsMembrane ProteinsNerve Growth FactorsNeuregulinsNRG2 protein, humanNrg2 protein, mousePhosphotyrosineReceptors, Growth Factor

Identifiers

PMID9199335
PMCPMC232253
OpenAlexW2122938403

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.